chr4-156767839-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_016205.3(PDGFC):āc.855C>Gā(p.Ala285=) variant causes a synonymous change. The variant allele was found at a frequency of 0.00342 in 1,613,346 control chromosomes in the GnomAD database, including 77 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0044 ( 9 hom., cov: 32)
Exomes š: 0.0033 ( 68 hom. )
Consequence
PDGFC
NM_016205.3 synonymous
NM_016205.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.80
Genes affected
PDGFC (HGNC:8801): (platelet derived growth factor C) The protein encoded by this gene is a member of the platelet-derived growth factor family. The four members of this family are mitogenic factors for cells of mesenchymal origin and are characterized by a core motif of eight cysteines. This gene product appears to form only homodimers. It differs from the platelet-derived growth factor alpha and beta polypeptides in having an unusual N-terminal domain, the CUB domain. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 4-156767839-G-C is Benign according to our data. Variant chr4-156767839-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 715728.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 674 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PDGFC | NM_016205.3 | c.855C>G | p.Ala285= | synonymous_variant | 5/6 | ENST00000502773.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PDGFC | ENST00000502773.6 | c.855C>G | p.Ala285= | synonymous_variant | 5/6 | 1 | NM_016205.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00444 AC: 674AN: 151944Hom.: 9 Cov.: 32
GnomAD3 genomes
AF:
AC:
674
AN:
151944
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00512 AC: 1286AN: 251074Hom.: 19 AF XY: 0.00470 AC XY: 638AN XY: 135674
GnomAD3 exomes
AF:
AC:
1286
AN:
251074
Hom.:
AF XY:
AC XY:
638
AN XY:
135674
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00331 AC: 4840AN: 1461284Hom.: 68 Cov.: 31 AF XY: 0.00329 AC XY: 2388AN XY: 726928
GnomAD4 exome
AF:
AC:
4840
AN:
1461284
Hom.:
Cov.:
31
AF XY:
AC XY:
2388
AN XY:
726928
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00443 AC: 674AN: 152062Hom.: 9 Cov.: 32 AF XY: 0.00519 AC XY: 386AN XY: 74324
GnomAD4 genome
AF:
AC:
674
AN:
152062
Hom.:
Cov.:
32
AF XY:
AC XY:
386
AN XY:
74324
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2023 | PDGFC: BP4, BP7, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at